While the majority of Class 1 (RAF dependent) MAP2K1 mutations are associated with co-mutation in BRAF, NRAS, or NF1, only a small proportion of class 2 (RAF regulated) cases and no class 3 (RAF regulated) cases share these co-mutations in a limited pan-cancer analysis [16]. Here, MAP2K1 is linked to cancer.